Alliance Pharmaceuticals Limited
Thierry CHRYSOSTOME has extensive experience in sales and management within the pharmaceutical and healthcare sectors. Currently serving as Directeur des ventes at Alliance Pharmaceuticals Limited since February 2017, Thierry previously held the position of Directeur de réseau - Directeur des ventes at Pharminov from January 2016 to February 2017. Prior to this, Thierry was Directeur de Zone Nord at GSA Healthcare within the Groupe GTF from January 2015 to January 2016. Notable earlier roles include co-founding and serving as Directeur associé at CENTURY 21® from June 2010 to October 2014, and holding several regional management positions at Sandoz and Boots Healthcare International from 2002 to 2009. Thierry began the career as Délégué Pharmaceutique at Laboratoires URGO and British American Tobacco from 1996 to 2002. Thierry CHRYSOSTOME holds qualifications from OMNES Education and NEGOCIA, specializing in sales and negotiation training.
This person is not in any teams
This person is not in any offices
Alliance Pharmaceuticals Limited
1 followers
We are Alliance Pharma plc, an international healthcare group. Our purpose is to improve the lives of consumers and patients, through making available a range of clinically valuable healthcare products. Headquartered in the UK, we employ more than 250 people based in locations across Europe, North America, and the Asia Pacific region. Our core focus is on the marketing of Consumer Healthcare brands. We also have a smaller Prescription Medicines business, which operates alongside this. In total, we hold marketing rights to around 80 brands, with our revenues being generated from a mix of direct, distributor and e-commerce sales. With annual revenues in excess of £160m, good margins and strong cash generation, we’re financially successful and have a strong appetite for growth. Outsourcing all of our manufacturing and logistics activities allows us to remain asset-light and to focus on leveraging the operating platform we’ve built across EMEA, AMER and APAC, in order to maximise the value and reach of our brands. For more information on Alliance, please visit our website: www.alliancepharmaceuticals.com Adverse Event Reporting Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Pharmacovigilance at Alliance Pharmaceuticals (tel: 01249 466966, email: pharmacovigilance@alliancepharma.co.uk)